Abstract
The product information ( 1 ) for human insulin inhalation powder (Exubera; Pfizer) recommends spirometry at baseline, 6 months postinitiation, and at least annually thereafter. Patients with a forced expiratory volume in the first second (FEV 1)
Original language | English |
---|---|
Pages (from-to) | 360-361 |
Journal | Diabetes Care |
Volume | 30 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2007 |